PT80681B - Alpha-omega-dicarbosaeuren verfahren zu ihrer herstellung und arzneimittel die diese verbindungen enthalten - Google Patents

Alpha-omega-dicarbosaeuren verfahren zu ihrer herstellung und arzneimittel die diese verbindungen enthalten

Info

Publication number
PT80681B
PT80681B PT80681A PT8068185A PT80681B PT 80681 B PT80681 B PT 80681B PT 80681 A PT80681 A PT 80681A PT 8068185 A PT8068185 A PT 8068185A PT 80681 B PT80681 B PT 80681B
Authority
PT
Portugal
Prior art keywords
dicarbosaurs
omega
alpha
compounds
manufacture
Prior art date
Application number
PT80681A
Other languages
German (de)
English (en)
Portuguese (pt)
Other versions
PT80681A (de
Original Assignee
Epis Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epis Sa filed Critical Epis Sa
Publication of PT80681A publication Critical patent/PT80681A/pt
Publication of PT80681B publication Critical patent/PT80681B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/42Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/26Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms containing rings other than aromatic rings
    • C07C55/28Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms containing rings other than aromatic rings monocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/32Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13Dicarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/34Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings containing more than one carboxyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/38Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/305Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/84Unsaturated compounds containing keto groups containing six membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT80681A 1984-06-22 1985-06-21 Alpha-omega-dicarbosaeuren verfahren zu ihrer herstellung und arzneimittel die diese verbindungen enthalten PT80681B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843423166 DE3423166A1 (de) 1984-06-22 1984-06-22 Alpha-, omega-dicarbonsaeuren, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten

Publications (2)

Publication Number Publication Date
PT80681A PT80681A (de) 1985-07-01
PT80681B true PT80681B (de) 1987-05-08

Family

ID=6238954

Family Applications (1)

Application Number Title Priority Date Filing Date
PT80681A PT80681B (de) 1984-06-22 1985-06-21 Alpha-omega-dicarbosaeuren verfahren zu ihrer herstellung und arzneimittel die diese verbindungen enthalten

Country Status (17)

Country Link
US (1) US4711896A (h)
EP (1) EP0185080B1 (h)
JP (1) JPH0780807B2 (h)
AU (1) AU4607185A (h)
CA (1) CA1262552A (h)
DD (1) DD240541A5 (h)
DE (2) DE3423166A1 (h)
DK (1) DK75986A (h)
ES (1) ES8604090A1 (h)
FI (1) FI860711A0 (h)
GR (1) GR851509B (h)
HU (1) HUT38892A (h)
IL (1) IL75549A (h)
NO (1) NO860661L (h)
PT (1) PT80681B (h)
WO (1) WO1986000298A1 (h)
ZA (1) ZA854684B (h)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4876279A (en) * 1986-05-05 1989-10-24 Merck & Co., Inc. Antihypercholesterolemic compounds
IL101708A (en) * 1992-04-28 1996-08-04 Senyorina Ltd Anti-fattening drugs comprising amino acid derivatives
US5602164A (en) * 1992-04-28 1997-02-11 Senyorina Ltd. Anti-obesity drugs
TW322493B (h) * 1994-06-27 1997-12-11 Shell Int Research
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
IL119971A (en) * 1997-01-07 2003-02-12 Yissum Res Dev Co Pharmaceutical compositions containing dicarboxylic acids and derivatives thereof and some novel dicarboxylic acids
IL121165A0 (en) 1997-06-26 1997-11-20 Yissum Res Dev Co Pharmaceutical compositions containing carboxylic acids and derivatives thereof
US20020037876A1 (en) * 1998-06-25 2002-03-28 Yissum Research Development Company Of Hebrew University Of Jerusalem Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
US6506799B1 (en) 1999-04-01 2003-01-14 Esperion Therapeutics, Inc. Methods of treating cardiovascular diseases, dyslipidemia, dyslipoproteinemia, and hypertension with ether compounds
US7304093B2 (en) * 2000-10-11 2007-12-04 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
CA2425311C (en) 2000-10-11 2011-06-14 Esperion Therapeutics, Inc. Ketone compounds and compositions for cholesterol management and related uses
AU2002211667A1 (en) 2000-10-11 2002-04-22 Esperion Therapeutics, Inc. Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
CA2425121A1 (en) 2000-10-11 2002-04-18 Esperion Therapeutics, Inc. Ether compounds and compositions for cholesterol management and related uses
IL155247A0 (en) 2000-10-11 2003-11-23 Esperion Therapeutics Inc Sulfide and disulfide compounds and compositions for cholesterol management and related uses
US20040122091A1 (en) * 2000-10-11 2004-06-24 Esperion Therapeutics, Inc. Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
US20050020694A1 (en) * 2001-10-11 2005-01-27 Dasseux Jean-Louis Henri Sulfide and disulfide compounds and compositions for cholesterol management and related uses
US20040192771A1 (en) * 2001-10-11 2004-09-30 Dasseux Jean-Louis Henri Ether compounds and compositions for cholesterol management and related uses
US20040204502A1 (en) * 2001-10-11 2004-10-14 Dasseux Jean-Louis Henri Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
EP1495034A2 (en) * 2002-04-10 2005-01-12 Esperion Therapeutics, Inc. Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
MXPA05000050A (es) * 2002-07-03 2005-04-08 Esperion Therapeutics Inc Composiciones farmaceuticas y metodos para tratar, prevenir y manejar el colesterol, dislipidemia y enfermedades relacionadas.
US20040048910A1 (en) * 2002-08-22 2004-03-11 Bove Susan Elizabeth Method of treating osteoarthritis
MX349134B (es) * 2003-01-23 2017-07-12 Esperion Therapeutics Inc Compuestos de hidroxilo y composiciones para el manejo del colesterol y usos relacionados.
WO2005002557A1 (en) * 2003-07-03 2005-01-13 Warner-Lambert Company Llc Pharmaceutical compositions including an ether and selective cox-2 inhibitor and uses thereof
EP1680099B1 (en) * 2003-11-07 2009-04-15 JJ Pharma, Inc. Hdl-boosting combination therapy complexes
US20050192347A1 (en) * 2003-12-23 2005-09-01 Dasseux Jean-Louis H. Urea and thiourea compounds and compositions for cholesterol management and related uses
US7705177B2 (en) 2003-12-24 2010-04-27 Esperion Therapuetics, Inc. Ketone compounds and compositions for cholesterol management and related uses
JP2007528369A (ja) * 2003-12-30 2007-10-11 シンドロメクス・リミテッド 3,3,14,14−テトラメチルヘキサデカン−1,16−ジオイック酸の投与法
JP2008502736A (ja) * 2004-06-09 2008-01-31 アバニール・ファーマシューティカルズ 高脂血症および関連疾患の治療のための複素環式誘導体
EP1753733A1 (en) * 2004-06-09 2007-02-21 Avanir Pharmaceuticals Small molecules for treatment of hypercholesterolemia and related diseases
MXJL06000068A (es) * 2004-06-09 2007-04-10 Avanir Pharmaceuticals Mediadores del transporte inverso de colesterol para el tratamiento de hipercolesterolemia.
US7846915B2 (en) * 2004-10-20 2010-12-07 Resverlogix Corporation Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
JP5368792B2 (ja) * 2005-07-29 2013-12-18 レスバーロジックス コーポレイション 複合疾患の予防および処置のための薬学的組成物および挿入可能な医療用デバイスによるその送達
NZ579355A (en) 2007-02-01 2012-03-30 Resverlogix Corp 2-(Aryl)-4-oxo-quinazoline derivatives
IL181577A0 (en) * 2007-02-26 2007-07-04 Jacob Bar Tana Combination therapy composition and methods for the treatment of cardiovascular disorders and immune-related disorders
US8481084B2 (en) 2007-05-23 2013-07-09 Amcol International Corporation Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal
PL2346837T3 (pl) 2008-06-26 2015-07-31 Resverlogix Corp Sposoby wytwarzania pochodnych chinazolinonu
EP2660238B1 (en) 2009-01-08 2015-05-06 Resverlogix Corporation Compounds for the prevention and treatment of cardiovascular disease
NZ708314A (en) 2009-03-18 2017-08-25 Resverlogix Corp Quinazolinones for use as anticancer agents
ES2821018T3 (es) 2009-04-22 2021-04-23 Resverlogix Corp Nuevos agentes antiinflamatorios
RU2538162C2 (ru) 2009-09-03 2015-01-10 Пфайзер Вэксинс ЭлЭлСи Вакцина против pcsk9
EP2618824A4 (en) 2010-09-20 2015-05-06 Kareus Therapeutics Sa METHOD AND COMPOSITIONS FOR TREATING DIABETES AND DYSLIPIDEMIA
US20140004142A1 (en) 2011-03-02 2014-01-02 Pfizer Inc. Pcsk9 vaccine
ES2745471T3 (es) 2011-11-01 2020-03-02 Resverlogix Corp Formulaciones orales de liberación inmediata para quinazolinonas sustituidas
EP2787986B1 (en) 2011-12-08 2017-10-18 Syndromex Ltd. Deuterated tetramethyl dioic acids, compositions comprising them and uses thereof
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
US9271978B2 (en) 2012-12-21 2016-03-01 Zenith Epigenetics Corp. Heterocyclic compounds as bromodomain inhibitors
WO2015123291A1 (en) 2014-02-11 2015-08-20 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Pcsk9 vaccine and methods of using the same
CA2978204A1 (en) 2015-03-13 2016-09-22 Esperion Therapeutics, Inc. Fixed dose combinations and formulations comprising etc1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease
WO2016147053A1 (en) 2015-03-13 2016-09-22 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases
MA41793A (fr) 2015-03-16 2018-01-23 Esperion Therapeutics Inc Associations de doses fixes comprenant du etc1002 et une ou plusieurs statines permettant de traiter ou de réduire un risque cardiovasculaire
CN107118098B (zh) * 2016-02-25 2020-07-14 中国科学院上海药物研究所 一类脂肪酸类化合物、其制备方法及其用途
US10512624B2 (en) 2016-11-30 2019-12-24 Syndromex Ltd. Long-chain amphipathic dicarboxylic acids for treatment of diabetes type-1
BR112021025928A2 (pt) 2019-06-21 2022-05-10 Esperion Therapeutics Inc Métodos de preparação de ácido bempedoico e composições do mesmo
TWI862642B (zh) 2019-07-26 2024-11-21 美商艾斯佩維他治療學公司 官能化的長鏈烴一元及二元羧酸及其用於預防或治療疾病的用途
WO2022159811A1 (en) 2021-01-25 2022-07-28 Espervita Therapeutics, Inc. Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of disease
TW202237073A (zh) * 2021-01-25 2022-10-01 美商艾斯佩維他治療學公司 官能化長鏈烴單羧酸及二羧酸及其衍生物以及其於預防或治療疾病之用途
CN115894220A (zh) * 2021-09-23 2023-04-04 中国科学院上海药物研究所 一类作用于acly的长链类化合物、其制备方法及其用途
CN115887435A (zh) * 2021-09-23 2023-04-04 博骥源(上海)生物医药有限公司 长链类化合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1210786B (de) * 1962-12-17 1966-02-17 Shell Int Research Verfahren zur Herstellung von p-Phenylen-bis (3, 3'-isovaleriansaeure) und 3-Phenylisovalerian-saeure
GB1556660A (en) * 1975-10-07 1979-11-28 Akzo Nv Di-carboxylic acid derivatives
IL64542A0 (en) * 1981-12-15 1982-03-31 Yissum Res Dev Co Long-chain alpha,omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FI860711A7 (fi) 1986-02-17
GR851509B (h) 1985-06-25
NO860661L (no) 1986-02-21
EP0185080A1 (h) 1986-06-25
PT80681A (de) 1985-07-01
DE3423166A1 (de) 1986-01-02
AU4607185A (en) 1986-01-24
HUT38892A (en) 1986-07-28
DE3574130D1 (en) 1989-12-14
JPS61502537A (ja) 1986-11-06
DK75986D0 (da) 1986-02-18
EP0185080B1 (de) 1989-11-08
IL75549A (en) 1989-03-31
JPH0780807B2 (ja) 1995-08-30
DK75986A (da) 1986-02-18
ES8604090A1 (es) 1986-02-01
US4711896A (en) 1987-12-08
CA1262552A (en) 1989-10-31
FI860711A0 (fi) 1986-02-17
WO1986000298A1 (fr) 1986-01-16
ZA854684B (en) 1986-02-26
DD240541A5 (de) 1986-11-05
IL75549A0 (en) 1985-10-31
ES544439A0 (es) 1986-02-01

Similar Documents

Publication Publication Date Title
PT80681B (de) Alpha-omega-dicarbosaeuren verfahren zu ihrer herstellung und arzneimittel die diese verbindungen enthalten
ATE18397T1 (de) Benzazepin-2-one, verfahren zu ihrer herstellung, pharmazeutische praeparate die diese verbindungen enthalten, sowie die verbindungen zur therapeutischen verwendung.
PT80476A (de) Neue aminotetralinderivate diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
PT80425A (de) Neue pyrrolo-benzimidazole verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
PT82169B (de) Neue sulfonylaminoathylverbindungen diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
PT82789A (de) Neue 2-arylmidazole diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE19875010I2 (de) Acetamidderivate Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
PT85335A (de) Neue benzolsulfonamido-indanylverbindungen diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
PT81605A (de) Imidazolylalkylguanidinderivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
PT80484B (de) Neue benzazepinderivate diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
PT81532A (de) Flavolignanderivate verfahren zu deren herstellung und arzneimittel die diese verbindungen enthalten
PT71533A (de) Acylharnstoffe insektizide mittel enthaltend diese verbindungen sowie verfahren zu ihrer herstellung
PT70009A (de) Immunstimulierende n-substituierte aziridin-2-carbonsaurederivate verfahren zu ihrer herstellung sowie arzneimittel die diese substanzen enthalten
PT85639A (de) Neue sulfonamido-athylverbindungen diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
PT71243A (de) Thiazolyliden-oxo-propionitrile insektizide mittel enthaltend diese verbindungen sowie verfahren zu ihrer herstellung
PT79289A (de) Chinazolinderivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
PT74096B (de) Acylharnstoffe insektizide mittel enthaltend diese verbindungen sowie verfahren zu ihrer herstellung
PT72981B (de) Neue substituierte 2(3h)-bezothiazolone verfahren zu ihrer herstellung ihre verwendung zur herstellung von arzneimitteln und arzneimittel die diese verbindungen enthalten
PT73124B (de) Carbamoyloxyamino-1,4-benzodiazepine verfahren zu ihrer herstellung und diese enthaltende arzneimittel
PT74077A (de) N-pyrimidinyl-carbaminsaureester verfahren zu ihrer herstellung und diese enthaltende arzneimittel
PT78923A (de) Propan-2-ol-derivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
PT81409B (de) 1,3,4-thiadiazolderivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
PT79288A (de) Sulfenamidderivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
PT75626A (de) Aminooxazolylverbindungen verfahren zu ihrer herstellung pharmazeutische praeparate welche diese verbindungen enthalten
PT86154A (de) Neue pyrrolo-benzimidazole diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19891109